Studying associative relations between left ventricular dysfunction and heart failure development in patients with acute coronary syndrome and clinical manifestation of COVID-19
DOI:
https://doi.org/10.14739/2310-1210.2025.1.316151Keywords:
percutaneous interventions, coronary artery bypass grafting, SARS-CoV-2 virus, left ventricular ejection fraction, heart failureAbstract
The aim of the work: to determine associative relations between left ventricular dysfunction and heart failure development in patients with acute coronary syndrome and COVID-19.
Materials and methods. Patients with acute coronary syndrome and manifestation of COVID-19 were included in the study (n = 100). The material for the analysis was the data of echocardiography and coronary angiography. The study participants underwent myocardial revascularization.
Results. It has been found that ejection fraction before reperfusion was 2.4 % higher in the main group (p ≥ 0.05), and it was increased by an average of 1.2 % (p ≥ 0.05) after reperfusion. In the comparison group, the mean value of ejection fraction did not differ before and after reperfusion. A comparative analysis of ejection fraction after reperfusion has shown its increase by an average of 52.0 % in the main group and by 48.0 % in the comparison group, indicating the treatment effectiveness. The determined OR coefficients have indicated a 0.85-fold reduced heart failure risk in the comparison group (OR = 0.85; 95 % CI: 0.36–2.01, p = 0.8). A 0.78 times decreased heart failure risk has been revealed in patients with unchanged ejection fraction after reperfusion in the comparison group (OR = 0.78; 95 % CI: 0.26–2.31, p = 0.8), while it has been shown to be 1.47 times higher in those with decreased ejection fraction (OR = 1.47; 95 % CI: 0.57–3.79, p = 0.5).
Conclusions. The determined OR coefficients have demonstrated associative relations between a reduction in the heart failure risk in single-vessel (OR = 0.67; 95 % CI: 0.06–7.31, p = 0.5), two-vessel (OR = 0.40; 95 % CI: 0.01–10.17, p = 0.5) and multivessel (OR = 0.79; 95 % CI: 0.26–2.38, p = 0.8) coronary artery lesions after effective reperfusion in the comparison group. Associative relations between increased risk of heart failure have been established in single-vessel (OR = 4.67; 95 % CI: 0.29–90.01, p = 0.4) and multivessel (OR = 3.29; 95 % CI: 0.74–16.66, p = 0.01; χ2 = 5.71) coronary artery lesions after ineffective revascularization.
References
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. doi: https://doi.org/10.1001/jamacardio.2020.1017. Erratum in: JAMA Cardiol. 2020;5(7):848. doi: https://doi.org/10.1001/jamacardio.2020.1722
Ruzzenenti G, Maloberti A, Giani V, Biolcati M, Leidi F, Monticelli M, et al. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective. High Blood Press Cardiovasc Prev. 2021;28(5):439-45. doi: https://doi.org/10.1007/s40292-021-00464-8
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8. doi: https://doi.org/10.1016/S0140-6736(20)30937-5
Rasputniak OV, Gavrilenko TI, Pidgaina OA, Trembovetska OM, Lomakovskyi OM, Shnaider LM. [Cardiovascular Complications of COVID-19: Review of Cardiac Injury Pathophysiology and Clinical Evidence]. Ukrainskyi zhurnal sertsevo-sudynnoi khirurhii. 2024;32(2):92-104. Ukrainian. doi: https://doi.org/10.30702/ujcvs/24.32(02)/RG021-92104
Karakasis P, Nasoufidou A, Sagris M, Fragakis N, Tsioufis K. Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review. Life (Basel). 2024;14(5):545. doi: https://doi.org/10.3390/life14050545
Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci. 2020;21(14):5168. doi: https://doi.org/10.3390/ijms21145168
Gungor B, Atici A, Baycan OF, Alici G, Ozturk F, Tugrul S, et al. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am J Emerg Med. 2021;39:173-9. doi: https://doi.org/10.1016/j.ajem.2020.09.018
Nwaedozie S, Rezkalla SH. ST Segment Elevation Myocardial Infarction in the COVID-19 Era: Appraisal of the Evidence. Clin Med Res. 2022;20(1):52-60. doi: https://doi.org/10.3121/cmr.2021.1707
Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: https://doi.org/10.1136/bmj.m1985
Fried MW, Crawford JM, Mospan AR, Watkins SE, Munoz B, Zink RC, et al. Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 (COVID-19) Hospitalized Across the United States. Clin Infect Dis. 2021;72(10):e558-65. doi: https://doi.org/10.1093/cid/ciaa1268
Jacquet-Lagrèze M, Riad Z, Hugon-Vallet E, Ferraris A, Fellahi JL. Left ventricular dysfunction in COVID-19: A diagnostic issue. Anaesth Crit Care Pain Med. 2020;39(3):393-4. doi: https://doi.org/10.1016/j.accpm.2020.05.015
Yang LC, Zhang RT, Guo LJ, Xiao H, Zu LY, Zhang YY, et al. [Hypoxia and inflammation are risk factors for acute myocardial injury in patients with coronavirus disease 2019]. Beijing Da Xue Xue Bao Yi Xue Ban. 2020;53(1):159-66. Chinese. doi: https://doi.org/10.19723/j.issn.1671-167X.2021.01.024
Toner L, Koshy AN, Hamilton GW, Clark D, Farouque O, Yudi MB. Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation. Eur Heart J Qual Care Clin Outcomes. 2020;6(3):225-6. doi: https://doi.org/10.1093/ehjqcco/qcaa038
Tam CF, Cheung KS, Lam S, Wong A, Yung A, Sze M, et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631. doi: https://doi.org/10.1161/CIRCOUTCOMES.120.006631
Bondarets D, Rudenko K. [Clinical peculiarities of acute coronary syndrome during COVID-19 manifestation]. Actual Problems of the Modern Medicine: Bulletin of Ukrainian Medical Stomatological Academy. 2024;24(4):25-9. Ukrainian. doi: https://doi.org/10.31718/2077-1096.24.4.25
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
